Adverse drug effects in hospitalized elderly: Data from the healthcare cost and utilization project

Clinical Pharmacology: Advances and Applications

Volumn 2, Issue 1, 2010, Pages 41-63

  Shamliyan, Tatyana ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adverse drug reaction reporting systems; Aged; Hospitalization; International classification of diseases

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTIRHEUMATIC AGENT; BARBITURIC ACID DERIVATIVE; CARDIAC GLYCOSIDE; CARDIOTONIC AGENT; CONTRAST MEDIUM; CORTICOSTEROID; DIURETIC AGENT; ERYTHROMYCIN DERIVATIVE; INSULIN DERIVATIVE; METHADONE; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; PENICILLIN DERIVATIVE; SALICYLIC ACID DERIVATIVE; TETRACYCLINE DERIVATIVE; TRANQUILIZER; UNINDEXED DRUG; VACCINE;

AGED HOSPITAL PATIENT; ARTICLE; BLEEDING; ELDERLY CARE; GASTRITIS; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; MEDICATION THERAPY MANAGEMENT; PATIENT SAFETY; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 77953469758     PISSN: None     EISSN: 11791438     Source Type: Journal    
DOI: 10.2147/cpaa.s8779     Document Type: Article

References (15)

1. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: Analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol. 2007;7:9.
2. Young PL, Olsen LA, McGinnis JM. Value in health care: Accounting for cost, quality, safety, outcomes, and innovation. Roundtable on Evidence-Based Medicine: Institute of Medicine; 2009: http://www.nap.edu/catalog/12566.html. Accessed March 10, 2009.
3. Kruzikas DT, Jiang HJ, Remus D, Barrett ML, Coffey RM, Andrews R. Preventable Hospitalizations: A Window Into Primary and Preventive Care, 2000. HCUP Fact Book No. 5; AHRQ Publication No. 04-0056. ISBN 1-58763-154-7;2004. Available from: http://www.ahrq.gov/data/hcup/factbk5/factbk5.pdf. Accessed March 10, 2010.
4. Levit KTR, Wier LTR, Stranges ETR, Ryan KTR, Elixhauser AA. HCUP facts and figures: Statistics on hospital-based care in the United States. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available from: http://www.hcup-us.ahrq.gov/reports.jsp. Accessed March 10, 2010.
5. HCUPnet. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. http://hcupnet.ahrq.gov. Accessed March 10, 2010.
6. ICD-9-CM: The International Classification Of Diseases, Ninth Revision, Clinical Modification. 4th ed. New York, NY: McGraw-Hill; 1994.
7. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107-1116.
8. Hougland P, Xu W, Pickard S, Masheter C, Williams SD. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system. Med Care. 2006;44(7):629-636.
9. Littell RC. SAS System for mixed models. 4th ed. Cary, NC; SAS Institute: 2000.
10. SAS Institute. SAS/AF 9.1 procedure guide. Cary, NC; SAS Institute: 2004. Available from: http://0-www.books24x7.com.catalog.kcls.org/marc.asp?isbn=159047225x. Accessed.
11. Leonard CE, Haynes K, Localio AR, et al. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol. 2008;61(6):561-571.
12. Naessens JM, Campbell CR, Huddleston JM, et al. A comparison of hospital adverse events identified by three widely used detection methods. Int J Qual Health Care. 2009;21(4):301-307.
13. Hanlon JT, Maher RL, Lindblad CI, et al. Comparison of methods for detecting potential adverse drug events in frail elderly inpatients and outpatients. Am J Health Syst Pharm. 2001;58(17):1622-1626.
14. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study. Impact of managed pharmaceutical care on resource utilization and outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20(12):1508-1516.
15. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med Singapore. 2004;33(2):220-227.